Transient Psychosis After Low-Dose Pregabalin Discontinuation

Am J Ther. 2022 Jul 1;29(4):478-479. doi: 10.1097/MJT.0000000000001159.
No abstract available

Publication types

  • Letter

MeSH terms

  • Analgesics
  • Anticonvulsants / therapeutic use
  • Humans
  • Pregabalin / adverse effects
  • Psychotic Disorders* / drug therapy
  • gamma-Aminobutyric Acid* / adverse effects

Substances

  • Analgesics
  • Anticonvulsants
  • Pregabalin
  • gamma-Aminobutyric Acid